DC Group Backs Pharma Cos. In Niaspan Pay-for-Delay Case
IP Law 360
MARCH 21, 2022
The Washington Legal Foundation has thrown its support behind AbbVie and Teva Pharmaceuticals, urging the Third Circuit in an amicus brief to reject an appeal from end-payors seeking class certification in their suit accusing the companies of delaying generic forms of cholesterol drug Niaspan from entering the market.
Let's personalize your content